Cargando…

Effects of reduced glutathione therapy on chronic hepatitis B

Developed chronic hepatitis B (CHB) causes death in approximately one million patients every year. Therefore, natural drugs with high therapeutic efficacy and minimal side effects must be developed for CHB treatment. This study aimed to relate the therapeutic effects of glutathione on CHB. A total o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Li, Wang, Wenjun, Zhou, Yan, Ma, Jianxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Society of Experimental and Clinical Immunology 2017
Materias:	Clinical Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470607/ https://www.ncbi.nlm.nih.gov/pubmed/28680337 http://dx.doi.org/10.5114/ceji.2016.65894

Ejemplares similares

Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone
por: Ren, Shan, et al.
Publicado: (2022)

Capabilities of hepatitis B surface antigen are divergent from hepatitis B virus DNA in delimiting natural history phases of chronic hepatitis B virus infection
por: Zhang, Zhanqing, et al.
Publicado: (2022)

Changes of natural killer cells’ phenotype in patients with chronic hepatitis B in intermittent interferon therapy
por: Bi, Xiaoyue, et al.
Publicado: (2023)

Stool vs. Serum Hepatitis B Virus DNA in Patients with Chronic Hepatitis B
por: Zheng, Ji-shun, et al.
Publicado: (2015)

KIR3DS1/HLA-B Bw4-80Ile Genotype Is Correlated with the IFN-α Therapy Response in hepatitis B e antigen-Positive Chronic Hepatitis B
por: Li, Wenting, et al.
Publicado: (2017)

Identification of an Autoantibody Against ErbB-3-Binding Protein-1 in the Sera of Patients With Chronic Hepatitis B Virus Infection
por: Jiang, Li, et al.
Publicado: (2021)

Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection
por: Wu, Shuling, et al.
Publicado: (2022)

Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients
por: Wang, Wen-Xin, et al.
Publicado: (2023)

Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy
por: Liu, Chao, et al.
Publicado: (2017)

Dynamic Perturbations of CD4 and CD8 T Cell Receptor Repertoires in Chronic Hepatitis B Patients upon Oral Antiviral Therapy
por: Xu, Ying, et al.
Publicado: (2017)

Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B
por: Xie, Si, et al.
Publicado: (2022)

Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis B
por: Klopp, Alexandre, et al.
Publicado: (2021)

Clinical characteristics of hepatitis flares during pregnancy and postpartum in Chinese chronic hepatitis B virus carriers—a prospective cohort study of 417 cases
por: Wang, Xiaoxiao, et al.
Publicado: (2022)

Hepatic glutathione and glutathione S-conjugate transport mechanisms.
por: Lee, T. K., et al.
Publicado: (1997)

Immune response to hepatitis B vaccination in pediatric patients with inflammatory bowel disease
por: BARANOWSKA-NOWAK, MARTA, et al.
Publicado: (2020)

Efficacy evaluation of direct antiviral drugs against hepatitis B virus in improving the degree of liver fibrosis
por: Miao, Liang, et al.
Publicado: (2023)

Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies
por: Sandhu, Praneet, et al.
Publicado: (2017)

Multiple CAR-T cell therapy for acute B-cell lymphoblastic leukemia after hematopoietic stem cell transplantation: A case report
por: Deng, Lei, et al.
Publicado: (2022)

Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg
por: Yang, Xiaoan, et al.
Publicado: (2022)

The immunological characteristics of TSPAN1 expressing B cells in autoimmune hepatitis
por: Ou, Yiyan, et al.
Publicado: (2022)

Interferon-α-Enhanced CD100/Plexin-B1/B2 Interactions Promote Natural Killer Cell Functions in Patients with Chronic Hepatitis C Virus Infection
por: He, Yu, et al.
Publicado: (2017)

Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection
por: Cerino, Antonella, et al.
Publicado: (2019)

High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection
por: Gu, Shuqin, et al.
Publicado: (2021)

Clinical Characteristics and Correlation Analysis of Subjects with Chronic Hepatitis B Virus (HBV) Infection and Sustained Low Levels of Hepatitis B Surface Antigen (HBsAg)
por: Cheng, Jun, et al.
Publicado: (2018)

Glutathione peroxidase and malondialdehyde in children with chronic hepatitis C
por: Khedr, Mohammed Ahmed, et al.
Publicado: (2019)

Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure
por: Zhu, Bingbing, et al.
Publicado: (2023)

Regulatory B Cells Dysregulated T Cell Function in an IL-35-Dependent Way in Patients With Chronic Hepatitis B
por: Liu, YaYun, et al.
Publicado: (2021)

Natural Killer Cells Induce CD8(+) T Cell Dysfunction via Galectin-9/TIM-3 in Chronic Hepatitis B Virus Infection
por: Liu, Siyu, et al.
Publicado: (2022)

Adoptive B cell therapy for chronic viral infection
por: Chung, Young Rock, et al.
Publicado: (2022)

NK Cells: A Double-Edged Sword in Chronic Hepatitis B Virus Infection
por: Maini, Mala K., et al.
Publicado: (2013)

BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection
por: Yu, Xueping, et al.
Publicado: (2019)

The relation of the frequency and functional molecules expression on plasmacytoid dendritic cells to postpartum hepatitis in women with HBeAg-positive chronic hepatitis B virus infection
por: Wang, Fuchuan, et al.
Publicado: (2022)

The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis
por: Teskey, Garrett, et al.
Publicado: (2018)

Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome
por: Carsetti, Rita, et al.
Publicado: (2015)

The Investigation of Hepatitis B Vaccine Immune Responses in Occult Hepatitis B Virus-Infected Patients
por: Peng, Jing, et al.
Publicado: (2022)

Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione
por: Allen, Michael, et al.
Publicado: (2015)

Vitamin B5 Reduces Bacterial Growth via Regulating Innate Immunity and Adaptive Immunity in Mice Infected with Mycobacterium tuberculosis
por: He, Wenting, et al.
Publicado: (2018)

Gender as a factor affecting NK cell activity in patients successfully treated for chronic hepatitis C with direct-acting antivirals
por: Zientarska, Agata, et al.
Publicado: (2021)

Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection
por: Meng, Zhongji, et al.
Publicado: (2020)

Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients
por: Wang, Wen-Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5jgon1bikopu6v0824sksrl6es